These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Cerebellar morphometric and spectroscopic biomarkers for Machado-Joseph Disease. Miranda CO; Nobre RJ; Paiva VH; Duarte JV; Castelhano J; Petrella LI; Sereno J; Santana M; Afonso S; Januário C; Castelo-Branco M; de Almeida LP Acta Neuropathol Commun; 2022 Mar; 10(1):37. PubMed ID: 35305685 [TBL] [Abstract][Full Text] [Related]
9. Autophagy in Spinocerebellar Ataxia Type 3: From Pathogenesis to Therapeutics. Paulino R; Nóbrega C Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108570 [TBL] [Abstract][Full Text] [Related]
10. Identification of the calpain-generated toxic fragment of ataxin-3 protein provides new avenues for therapy of Machado-Joseph disease| Spinocerebellar ataxia type 3. Simões AT; Carmona V; Duarte-Neves J; Cunha-Santos J; Pereira de Almeida L Neuropathol Appl Neurobiol; 2022 Feb; 48(1):e12748. PubMed ID: 34273111 [TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y mitigates neuropathology and motor deficits in mouse models of Machado-Joseph disease. Duarte-Neves J; Gonçalves N; Cunha-Santos J; Simões AT; den Dunnen WF; Hirai H; Kügler S; Cavadas C; Pereira de Almeida L Hum Mol Genet; 2015 Oct; 24(19):5451-63. PubMed ID: 26220979 [TBL] [Abstract][Full Text] [Related]
12. Silencing mutant ataxin-3 rescues motor deficits and neuropathology in Machado-Joseph disease transgenic mice. Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Hirai H; Déglon N; de Almeida LP PLoS One; 2013; 8(1):e52396. PubMed ID: 23349684 [TBL] [Abstract][Full Text] [Related]
13. Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models. Mendonça LS; Nóbrega C; Tavino S; Brinkhaus M; Matos C; Tomé S; Moreira R; Henriques D; Kaspar BK; Pereira de Almeida L Hum Mol Genet; 2019 Nov; 28(22):3691-3703. PubMed ID: 31127937 [TBL] [Abstract][Full Text] [Related]
14. Caloric restriction blocks neuropathology and motor deficits in Machado-Joseph disease mouse models through SIRT1 pathway. Cunha-Santos J; Duarte-Neves J; Carmona V; Guarente L; Pereira de Almeida L; Cavadas C Nat Commun; 2016 May; 7():11445. PubMed ID: 27165717 [TBL] [Abstract][Full Text] [Related]
15. Altered glucose metabolism and its association with carbonic anhydrase 8 in Machado-Joseph Disease. Lin GY; Ma CY; Kuo LC; Hsieh BY; Wang H; Liu CS; Hsieh M Metab Brain Dis; 2022 Aug; 37(6):2103-2120. PubMed ID: 35488942 [TBL] [Abstract][Full Text] [Related]
16. Citalopram Reduces Aggregation of ATXN3 in a YAC Transgenic Mouse Model of Machado-Joseph Disease. Ashraf NS; Duarte-Silva S; Shaw ED; Maciel P; Paulson HL; Teixeira-Castro A; Costa MDC Mol Neurobiol; 2019 May; 56(5):3690-3701. PubMed ID: 30187384 [TBL] [Abstract][Full Text] [Related]
18. Protective roles of carbonic anhydrase 8 in Machado-Joseph Disease. Hsieh M; Hsieh BY; Ma CY; Li YT; Liu CS; Lo CM J Neurosci Res; 2019 Oct; 97(10):1278-1297. PubMed ID: 31157458 [TBL] [Abstract][Full Text] [Related]